Diazoxide induced pulmonary hypertension
Neonatal status epilepticus
Hypoxic ischemic encephalopathy
Serio J, Gattoline S, Collier H, Bustin A. Evaluation of sirolimus dosing in neonates and infants with lymphatic disorders. J Pediatr Pharmacol Ther. J Pediatr Pharmacol Ther. 2022;27(5):447-458.
McElroy NA, Bustin A, Gattoline S. Evaluation of the Safety of Ketorolac in Postsurgical Infants Less than Six Months of Age. J Pediatr Pharmacol Ther. J Pediatr Pharmacol Ther. 2022;27(4):347–351
Sanseau E, et al. Pediatric Emergency Medicine Simulation Curriculum: Vitamin K Deficiency in the Newborn. MedEdPORTAL. 2021;17:11078
Bustin A, Ramsey EZ, Hanna BD, Kaushal G. Compatibility of treprostinil sodium and dopamine hydrochloride during Y-site administration. Am J Health-Syst Pharm. 2020;77:649-657
Posters and Presentations
Napolitano N and Bustin A. Utilization of Aerosolized Medications in sBPD: Evidence vs. Eminence-Based Medicine. Eighth Annual Children’s Hospital of Philadelphia Chronic Lung Disease Conference. Philadelphia, Pennsylvania. June 2022.
Nelin TD.; Jensen EA.; Lorch S; Gibbs K; Alexiou S; Napolitano N; Bustin A; Huber M; Bamat NA. Impact of novel loop and thiazide diuretic exposures on serum sodium, potassium, and chloride in infants with severe bronchopulmonary dysplasia. Pediatric Academic Societies 2022 Conference. Denver, Colorado. April 2022.
Napolitano N, Malick E, Bamat NA, Bustin A, Gibbs K, Jensen EA, Panitch H. Formoterol use in Infants with Severe Bronchopulmonary Dysplasia: A case series. Society of Critical Care Medicine 2022 Conference. Virtual Platform. February 2022.
Salmon M, Abend NA, Bustin A, Fitzgerald MP, Flibotte J, Fung FW, Parikh D, Massey SL. Seizure Management in Neonatal Hypoxic Ischemic Encephalopathy. Child Neurology Society 2021 Annual Meeting. Poster Presentation. Boston, MA. October 2021.
Monk HM, Rosano JV, Bustin A. Characterization of the use, safety, and efficacy of hydromorphone in the neonatal and infant population. 2018 ASHP Midyear Meeting Poster Presentation. Anaheim, California. December 2018.
Leadership and Memberships
Memberships in Professional Organizations
Pediatric Pharmacy Association (PPA)
American Society of Health-System Pharmacists (ASHP)
Patient Experience Ratings
About the Patient Experience Rating System
The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments.
Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care.
The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.